can we sue gsk for breach/poor marketing

Surely BTA have in their contract with GSK for Key Deliverables for Supply and Marketing of Relenza.

Granted if demand is poor for the product as a result on no=needs basis then GSK is not at fault, but demand has been in great demand via the pandemic and demand is still their for new product Lamir (albeit only in Japan at the moment)

Remember GSK has the whole world to market Relenza which I do not believe they have done on a Professional basis.

PC you walked away from the previous Legal battle with nothing and gave away a great out of Court offer.

I think you should be looking at going for GSK again and try and get some real value to shareholders folr the remainder of the licencing timelife for Relenza

Go Peter, Go.

Do it or just Go Go as you have provided little to nothing of value to shareholders.